Jump to main content
Jump to site search

Issue 65, 2017
Previous Article Next Article

Redox-responsive xanthene–coumarin–chlorambucil-based FRET-guided theranostics for “activatable” combination therapy with real-time monitoring

Author affiliations

Abstract

A FRET donor–acceptor xanthene–coumarin conjugate has been designed for redox-regulated synergic treatment of photodynamic therapy and chemotherapy with real-time monitoring. The “locked” FRET pair was selectively “unlocked” by biological reducing thiols via rupture of a sacrificial disulfide linker. A distinct change in fluorescence color and selective cancer cell toxicity were observed in vitro.

Graphical abstract: Redox-responsive xanthene–coumarin–chlorambucil-based FRET-guided theranostics for “activatable” combination therapy with real-time monitoring

Back to tab navigation

Supplementary files

Publication details

The article was received on 26 Apr 2017, accepted on 25 Jul 2017 and first published on 25 Jul 2017


Article type: Communication
DOI: 10.1039/C7CC03241B
Chem. Commun., 2017,53, 9109-9112

  •   Request permissions

    Redox-responsive xanthene–coumarin–chlorambucil-based FRET-guided theranostics for “activatable” combination therapy with real-time monitoring

    M. Gangopadhyay, R. Mengji, A. Paul, Y. Venkatesh, V. Vangala, A. Jana and N. D. P. Singh, Chem. Commun., 2017, 53, 9109
    DOI: 10.1039/C7CC03241B

Search articles by author

Spotlight

Advertisements